述评
ENGLISH ABSTRACT
胃癌保功能手术的发展现状和前景展望
邢继尧
苗儒林
陕飞
李子禹
作者及单位信息
·
DOI: 10.3760/cma.j.cn441530-20250103-00006
Development status and prospects of functional preservation surgery for gastric cancer
Xing Jiyao
Miao Rulin
Shan Fei
Li Ziyu
Authors Info & Affiliations
Xing Jiyao
Gastrointestinal Tumor Center, Peking University Cancer Hospital & Institute, Beijing Institute for Cancer Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
Miao Rulin
Gastrointestinal Tumor Center, Peking University Cancer Hospital & Institute, Beijing Institute for Cancer Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
Shan Fei
Gastrointestinal Tumor Center, Peking University Cancer Hospital & Institute, Beijing Institute for Cancer Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
Li Ziyu
Gastrointestinal Tumor Center, Peking University Cancer Hospital & Institute, Beijing Institute for Cancer Research, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
·
DOI: 10.3760/cma.j.cn441530-20250103-00006
131
23
0
0
1
0
PDF下载
APP内阅读
摘要

胃癌保功能手术是一种以改善术后功能为核心目标的治疗策略,在确保肿瘤学安全性的前提下,通过保留贲门、幽门和迷走神经等重要解剖结构以及消化、分泌、排空和抗反流等关键功能,最大限度地减少对患者术后生活质量的负面影响。随着新辅助治疗模式的广泛应用和抗肿瘤药物疗效的不断提高,保功能手术的应用前景和适应证范围也有望进一步拓展。本文从胃癌保功能手术的主要类型、新辅助治疗后的应用以及新技术探索等方面阐述其发展现状和未来前景。

胃肿瘤;保功能手术;新辅助治疗
ABSTRACT

Function-preserving surgery for gastric cancer is a treatment strategy aimed at improving postoperative function while ensuring oncological safety. By preserving important anatomical structures such as the cardia, pylorus, and vagus nerve, as well as key functions like digestion, secretion, emptying, and anti-reflux, this approach aims to minimize the negative impact on patients' postoperative quality of life. With the widespread application of neoadjuvant treatment and the continuous improvement in the efficacy of anti-tumor drugs, the application and indications for functional-preserving surgery may further expand. This article reviews the current status and future prospects of function-preserving surgery for gastric cancer, focusing on its main types, applications after neoadjuvant therapy, and the exploration of new technologies.

Stomach neoplasms;Functional preservation surgery;Neoadjuvant therapy
Li Ziyu, Email: mocdef.kabooltuoyrogergil
引用本文

邢继尧,苗儒林,陕飞,等. 胃癌保功能手术的发展现状和前景展望[J]. 中华胃肠外科杂志,2025,28(02):127-133.

DOI:10.3760/cma.j.cn441530-20250103-00006

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
胃癌保功能手术是一种以改善术后功能为核心目标的治疗策略,在确保肿瘤学安全性的前提下,通过保留贲门、幽门和迷走神经等重要解剖结构以及消化、分泌、胃排空和抗反流等关键功能,最大限度地减少对患者生活质量的负面影响。根据《中国胃癌保功能手术外科专家共识(2021版)》,保功能手术主要适用于早期胃癌患者,其核心是在缩小手术范围、合理选择消化道重建方式的基础上,兼顾肿瘤根治性与患者生活质量 1
早期胃癌淋巴结转移风险较低,患者预后良好,5年生存率可达90%以上,是保功能手术的主要适应证 2。随着胃镜筛查的普及,我国早期胃癌的诊断率逐年提高。2017年中国胃肠肿瘤外科联盟数据显示,我国外科治疗患者中早期胃癌的比例为19.5% 3。但目前我国胃癌患者仍以局部进展期为主,对保功能手术的广泛应用构成了挑战。近年来,新辅助治疗模式的普及为局部进展期胃癌的外科治疗策略带来了新的思考。新辅助化疗有助于降低肿瘤分期,部分患者甚至可达到病理完全缓解(pathological complete response,pCR) 4。随着免疫检查点抑制剂等在临床中的应用,进一步助力了抗肿瘤疗效 5。加之放疗、靶向药物等的研究进展,为保功能手术适应证人群的拓展提供了可能性。新辅助治疗后获得降期的局部进展期胃癌患者,不失为保功能手术潜在的选择人群。本文将从胃癌保功能手术的主要类型、新辅助治疗后的应用以及新技术探索等方面,阐述其发展现状和未来前景,以期为临床实践提供新的启示。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
中华医学会外科学分会胃肠学组,中国医师协会外科医师分会肿瘤外科学组,中国医师学会外科医师分会上消化道学组,中国抗癌协会肿瘤胃肠病学分会. 中国胃癌保功能手术外科专家共识(2021版)[J]. 中华胃肠外科杂志, 2021,24(5):377-382. DOI: 10.3760/cma.j.issn.441530-20210305-00102 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Allemani C , Matsuda T , Carlo VD ,et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population- based registries in 71 countries[J]. Lancet, 2018,391(10125):1023-7105. DOI: 10.1016/S0140-6736(17)33326-3 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
中国胃肠肿瘤外科联盟. 中国胃肠肿瘤外科联盟数据报告(2014-2016)[J]. 中国实用外科杂志, 2018,38(1):90-93. DOI: 10.19538/j.cjps.issn1005-2208.2018.01.20 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Cunningham D , Allum WH , Stenning SP ,et al. Perioperative chemothera py versus surgery alone for resectable gastroesophageal cancer [J]. N Engl J Med, 2006,355(1):11-20. DOI: 10.1056/NEJMoa055531 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
Shitara K , Rha SY , Wyrwicz LS ,et al. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE- 585): an interim analysis of the multicentre, double-blind, randomised phase 3 study[J]. Lancet Oncol, 2024,25(2):212-224. DOI: 10.1016/S1470-2045(23)00541-7 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)[J]. Gastric Cancer, 2023,26(1):1-25. DOI: 10.1007/s10120-022-01331-8 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Hiki N , Yamamoto Y , Fukunaga T ,et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection[J]. Surg Endosc, 2008,22(7):1729-1735. DOI: 10.1007/s00464-007-9696-8 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Eom BW , Kim CG , Kook MC ,et al. Feasibility of non- Exposure simple suturing endoscopic full-thickness resection in comparison with laparoscopic endoscopic cooperative surgery for gastric subepithelial tumors: results of two independent prospective trials[J]. Cancers (Basel), 2021,13(8):1858. DOI: 10.3390/cancers13081858 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Kikuchi S , Nishizaki M , Kuroda S ,et al. Nonexposure laparoscopic and endoscopic cooperative surgery (closed laparoscopic and endoscopic cooperative surgery) for gastric submucosal tumor[J]. Gastric Cancer, 2017,20(3):553-557. DOI: 10.1007/s10120-016-0641-1 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Kitakata H , Itoh T , Kinami S ,et al. Sealed endoscopic full-thickness resection for gastric cancer: a pilot study in an ex vivo and in vivo porcine model[J]. Endosc Int Open, 2019,7(1):E36-E42. DOI: 10.1055/a-0777-1954 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Nunobe S , Hiki N , Gotoda T ,et al. Successful application of laparoscopic and endoscopic cooperative surgery (LECS) for a lateral-spreading mucosal gastric cancer[J]. Gastric Cancer, 2012,15(3):338-342. DOI: 10.1007/s10120-012-0146-5 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Zhao PY , Ma ZF , Jiao YN ,et al. Laparoscopic and endoscopic cooperative surgery for early gastric cancer: perspective for actual practice[J]. Front Oncol, 2022,12:969628. DOI: 10.3389/fonc.2022.969628 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Miyashiro I , Hiratsuka M , <x>Sa</x> <x>sako</x> M ,et al. High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302[J]. Gastric Cancer, 2014,17(2):316-323. DOI: 10.1007/s10120-013-0285-3 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Min JS , Seo KW , Jeong SH . Choice of LECS procedure for benign and malignant gastric tumors[J]. J Gastric Cancer, 2021,21(2):111-121. DOI: 10.5230/jgc.2021.21.e21 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
邢继尧,苗儒林,吴齐,. 腹腔镜-内镜联合手术治疗早期胃癌初期病例技术分析[J]. 中国肿瘤临床, 2024,51(13):670-675. DOI: 10.12354/j.issn.1000-8179.2024.20240779 .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Maki T , Shiratori T , Sugawara K . Technic in gastrectomy preserving the pylorus[J]. Shujutsu, 1966,20(3):169-173.
返回引文位置Google Scholar
百度学术
万方数据
[17]
Kodama M , Koyama K . Indications for pylorus preserving gastrectomy for early gastric cancer located in the middle third of the stomach[J]. World J Surg, 1991,15(5):628-634. DOI: 10.1007/BF01789211 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Fujimura T , Fushida S , Kayahara M ,et al. Transectional gastrectomy: an old but renewed concept for early gastric cancer[J]. Surg Today, 2010,40(5):398-403. DOI: 10.1007/s00595-009-4151-1 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Kim BH , Hong SW , Kim JW ,et al. Oncologic safety of pylorus-preserving gastrectomy in the aspect of micrometastasis in lymph nodes at stations 5 and 6[J]. Ann Surg Oncol, 2014,21(2):533-538. DOI: 10.1245/s10434-013-3252-7 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Park DJ , Kim YW , Yang HK ,et al. Short-term outcomes of a multicentre randomized clinical t rial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial) [J]. Br J Surg, 2021,108(9):1043-1049. DOI: 10.1093/bjs/znab295 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Kodama M , Koyama K , Chida T ,et al. Early postoperative evaluation of pylorus-preserving gastrectomy for gastric cancer[J]. World J Surg, 1995,19(3):456-461. DOI: 10.1007/BF00299190 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
中国抗癌协会胃癌专业委员会. 近端胃切除消化道重建中国专家共识(2024版)[J]. 中华胃肠外科杂志, 2024,27(10):983-995. DOI: 10.3760/cma.j.cn441530-20240918-00323 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Tanioka T , Waratchanont R , Fukuyo R ,et al. Surgical and nutritional outcomes of laparoscopic proximal gastrectomy versus total gastrectomy: a meta-analysis[J]. Surg Endosc, 2020,34(3):1061-1069. DOI: 10.1007/s00464-019-07352-2 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Ding SK , Zheng XH , Wang SH ,et al. Long-term nutritional status after total gastrectomy was comparable to proximal gastrectomy but with much less reflux esophagitis and anastomotic stenosis[J]. Front Oncol, 2022,12:973902. DOI: 10.3389/fonc.2022.973902 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
王胤奎,李子禹,季加孚. 腹腔镜辅助近端胃切除术拱桥式消化道重建的重点与难点[J]. 中国实用外科杂志, 2022,42(10):1194-1196. DOI: 10.19538/j.cjps.issn1005-2208.2022.10.25 .
返回引文位置Google Scholar
百度学术
万方数据
[26]
Wang FH , Zhang XT , Tang L ,et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023[J]. Cancer Commun (Lond), 2024,44(1):127-172. DOI: 10.1002/cac2.12516 .
返回引文位置Google Scholar
百度学术
万方数据
[27]
Byrd DR , Brierley JD , Baker TP ,et al. Current and future cancer staging after neoadjuvant treatment for solid tumors[J]. CA Cancer J Clin, 2021,71(2):140-148. DOI: 10.3322/caac.21640 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Fukagawa T , Katai H , Mizusawa J ,et al. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A)[J]. Gastric Cancer, 2018,21(1):68-73. DOI: 10.1007/s10120-017-0701-1 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
王胤奎,王宇宸,陕飞,. 基于临床分期探索胃癌新辅助化疗潜在获益人群的单中心回顾性研究[J]. 中华胃肠外科杂志, 2020,23(2):152-157. DOI: 10.3760/cma.j.issn.1671-0274.2020.02.010 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
BeckerR K , Langer R , Reim D ,et al. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases[J]. Ann Surg, 2011,253(5):934-939. DOI: 10.1097/SLA.0b013e318216f449 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Fanelli GN , Loupakis F , Smyth E ,et al. Pathological tumor regression grade classifications in gastrointestinal cancers: role on patients' prognosis[J]. Int J Surg Pathol, 2019,27(8):816-835. DOI: 10.1177/1066896919869477 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Zhang X , Liang H , Li Z ,et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial[J]. Lancet Oncol, 2021,22(8):1081-1092. DOI: 10.1016/S1470-2045(21)00297-7 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
陈杰,刘凤林. 胃癌新辅助治疗后病理完全缓解的意义及治疗策略[J]. 中华胃肠外科杂志, 2024,27(7):666-671. DOI: 10.3760/cma.j.cn441530-20240425-00153 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
中国直肠癌新辅助治疗后等待观察数据库研究协作组,中华医学会外科学分会结直肠外科学组,中国医师协会结直肠肿瘤医师专业委员会,. 直肠癌新辅助治疗后等待观察策略中国专家共识(2024版)[J]. 中华胃肠外科杂志, 2024,27(4):301-315. DOI: 10.3760/cma.j.cn441530-20240227-00075 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Kuerer HM , Smith BD , Krishnamuthy S ,et al. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial[J]. Lancet Oncol, 2022,23(12):1517-1524. DOI: 10.1016/S1470-2045(22)00613-1 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Gu TF , Wang YK , Wu ZQ ,et al. Feasibility and long-term survival of proximal gastrectomy after neoadjuvant therapy for locally advanced proximal gastric cancer: A propensity-score-matched analysis[J]. Chin Med J (Engl), 2024. DOI: 10.1097/CM9.0000000000003232 .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Yuan Z , Cui H , Xu Q ,et al. Total versus proximal gastrectomy for proximal gastric cancer after neoadjuvant chemotherapy: a multicenter retrospective propensity score-matched cohort study[J]. Int J Surg, 2024,110(2):1000-1007. DOI: 10.1097/JS9.0000000000000927 .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Kitagawa Y , Takeuchi H , Takagi Y ,et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan[J]. J Clin Oncol, 2013,31(29):3704-3710. DOI: 10.1200/JCO.2013.50.3789 .
返回引文位置Google Scholar
百度学术
万方数据
[39]
Tang L , Wang XJ , Baba H ,et al. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and 18 F-FDG PET/CT findings [J]. European radiology, 2020,30(1):247-260. DOI: 10.1007/s00330-019-06370-x .
返回引文位置Google Scholar
百度学术
万方数据
[40]
Huffman BM , Aushev VN , Budde GL ,et al. Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancers[J]. JCO Precis Oncol, 2022,6:e2200420. DOI: 10.1200/PO.22.00420 .
返回引文位置Google Scholar
百度学术
万方数据
[41]
中国医师协会外科医师分会上消化道外科医师专家工作组. 胃癌分子残留病灶 检测与临床应用中国专家共识(2023版) [J]. 中华消化外科杂志, 2023,22(10):1147-1154. DOI: 10.3760/cma.j.cn115610-20231008-00129 .
返回引文位置Google Scholar
百度学术
万方数据
[42]
Dong D , Tang L , Li Z Y ,et al. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer[J]. Ann Oncol, 2019,30(3):431-438. DOI: 10.1093/annonc/mdz001 .
返回引文位置Google Scholar
百度学术
万方数据
[43]
Boehm KM , Khosravi P , Vanguri R ,et al. Harnessing multimodal data integration to advance precision oncology[J]. Nat Yev Cancer, 2022,22(2):114-126. 10.1038/s41568-021-00408-3 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
李子禹,Email: mocdef.kabooltuoyrogergil
B
邢继尧, 苗儒林, 陕飞, 等. 胃癌保功能手术的发展现状和前景展望[J]. 中华胃肠外科杂志, 2025, 28(2): 127-133. DOI: 10.3760/cma.j.cn441530-20250103-00006.
C
所有作者均声明不存在利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号